Leda Gattoc, MD
Gynecologic Oncology · Atlanta, GANPI 1073751731
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,902 of the $6,515 with a category attached, or 75.2%. 35 manufacturers reported payments, led by Intuitive Surgical at 28.6% of the total.
Across 202 payments — averaging $32.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Merck$927
- AstraZeneca$611
- GSK$583
- Eisai Inc.$550
- Smith+Nephew$387
- plus $2K from 29 others
What the payments were for
- Travel & lodging$5478%
- Food & beverage$4,90275%
- Education$1,05116%
- Gifts$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $1,862 |
| Merck | 39 | $927 |
| AstraZeneca(2 entities) | 30 | $611 |
| GSK | 22 | $583 |
| Eisai Inc. | 21 | $550 |
| Smith+Nephew | 12 | $387 |
| Pfizer | 7 | $148 |
| Daiichi Sankyo Inc. | 7 | $146 |
| Novartis | 5 | $116 |
| Johnson & Johnson(2 entities) | 6 | $115 |
| Seagen Inc. | 5 | $103 |
| Coherus Oncology, Inc. | 4 | $94 |
| Myriad Genetic Laboratories, Inc. | 4 | $91 |
| Genentech USA, Inc. | 4 | $85 |
| Astellas Pharma US Inc | 3 | $81 |
| Jazz Pharmaceuticals Inc. | 2 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| Karyopharm Therapeutics Inc. | 2 | $51 |
| Caris MPI, Inc. | 2 | $50 |
| Servier Pharmaceuticals LLC | 2 | $50 |
| Immunogen, Inc. | 2 | $43 |
| Exelixis Inc. | 1 | $31 |
| Conmed Corporation | 1 | $29 |
| Iovance Biotherapeutics, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $24 |
| Blue Earth Diagnostics | 1 | $23 |
| Springworks Therapeutics, Inc. | 1 | $21 |
| Davol Inc. | 1 | $21 |
| Bayer | 1 | $18 |
| Mimedx Group, Inc. | 1 | $17 |
| Solventum Corporation | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Tesaro, Inc. | 1 | $14 |
| Meditrina | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,000
- Da Vinci Surgical System$808
- Grafix$249
- KEYTRUDA$125
- Stravix$105
How this compares
$6,515 in reported general payments places this provider in the 70th percentile of 49 gynecologic oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LynparzaOlaparib | 12 | $204,818 |
| Estradiol | 12 | $707 |
| Oxycodone Hcl | 40 | $155 |
| Ibuprofen | 21 | $76 |
| Tramadol Hcl | 21 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaLynparza | $611 | $204,81812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 49 gynecologic oncology providers in Georgia.
Other gynecologic oncology in Atlanta
- Benedict BenignoAtlanta$273K
- Adam PyrzakAtlanta$116K
- Gerald FeuerAtlanta$102K
- Guilherme CantuariaAtlanta$13K
- Cyril SpannAtlanta$12K
- Kevin AultAtlanta$10K
- Jennifer ScaliciAtlanta$6K
- Oi Wah YapAtlanta$3K
- Namita KhannaAtlanta$3K
- Joseph BoveriAtlanta$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.